AI-Driven Diabetes Care and Its Relevance in the Philippine Context: Opportunities and Persistent Digital Barriers

I read with great interest the article by Kelly et al. on the cost-effective improvement of quality of life and reduction of health care professional burnout through an artificial intelligence (AI)-driven intervention for personalized diabetes care. ¹ The study demonstrates that digital health platforms such as Spotlight-AQ can improve clinical efficiency, enhance patient outcomes, and reduce clinician burnout, with gains in quality-adjusted life years and reduced emotional exhaustion among health care professionals.

In the Philippine context, these findings are highly relevant given the growing burden of diabetes mellitus, which remains one of the leading non-communicable diseases among Filipino adults. ² This burden is compounded by late diagnosis, suboptimal glycemic control, and high treatment costs, all of which place significant strain on patients and the health care system. ³ Artificial intelligence-driven interventions that streamline consultations and support personalized care therefore have strong potential to improve diabetes management and reduce workload pressures in overstretched clinical settings.

However, the implementation of such innovations must be viewed in light of persistent health system inequalities in the Philippines. While urban areas may have stable internet access and growing familiarity with digital health tools, many rural and geographically isolated communities continue to experience limited or unstable connectivity. ⁴ This digital divide remains a major barrier to the sustained use of AI-driven diabetes platforms, particularly among older adults who already face difficulties in managing complex treatment regimens.

Digital literacy is also uneven among Filipino patients with diabetes. Many older adults have limited experience using mobile applications or AI-based health platforms, which may hinder effective adoption without structured training and ongoing support. ⁵ In addition, diabetes in the Philippines is frequently complicated by visual impairment due to diabetic retinopathy and cataract, further limiting patients’ ability to interact with digital tools. ⁶ Without inclusive design features such as voice-assisted interfaces and simplified navigation, there is a risk of excluding vulnerable populations from these innovations.

Despite these challenges, AI-driven diabetes care remains a promising strategy for strengthening chronic disease management in the Philippines. When appropriately localized, such platforms may enhance care coordination, improve decision-making efficiency, and support clinicians managing high patient volumes. However, successful implementation requires parallel investment in digital infrastructure, patient education, and workforce training to ensure equitable access and usability.

Ultimately, the effectiveness of AI in diabetes care should be assessed not only in terms of cost-effectiveness and clinical outcomes but also by its accessibility in resource-limited and digitally diverse settings. Addressing structural and technological barriers will be essential to ensure that AI-driven innovations contribute meaningfully to reducing the burden of diabetes and improving population health outcomes in the Philippines.